- GlaxoSmithKline, Moderna, and Sinovac are leveraging the influenza vaccine market, with Phase 3 trials showing strong immune responses.
- Moderna's vaccine demonstrated superior efficacy compared to GSK's flu shot on July 1, 2025.
Positive test results were reported for Moderna's flu vaccine.
2 reports, 1 independent
Updated Sep 2
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Positive test results were reported for Moderna's flu vaccine.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Positive late-stage trial results reported for Moderna's mRNA vaccine.1 source
- Specific positive test results for the Moderna flu vaccine were reported.
Keep exploring
The entities involved
-
Moderna
American biotechnology company
- Analyst downgrades and market challenges are impacting Moderna amid waning demand for COVID-19 vaccines, alongside pipeline successes.
- Trump's policies, including tariffs and onshoring, are being discussed in the context of their potential benefits for AI stocks, with specific attention paid to Moderna's performance and guidance.
Related events
- Moderna and Merck are developing cancer vaccines in partnership, while Moderna is also seeking approval for its seasonal influenza vaccine.
- Stella Parton donated $1 million to support COVID-19 research into mRNA vaccines.
- Moderna and Merck are seeking FDA review for a novel cancer treatment, having co-led a Phase 3 mRNA vaccine trial.
Coverage
Newest first; wire copies grouped- yahoo.com
- Unknown outlet